6-33305294-G-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_003190.5(TAPBP):c.563C>T(p.Thr188Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000254 in 1,579,442 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_003190.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAPBP | NM_003190.5 | c.563C>T | p.Thr188Ile | missense_variant | 4/8 | ENST00000434618.7 | NP_003181.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAPBP | ENST00000434618.7 | c.563C>T | p.Thr188Ile | missense_variant | 4/8 | 1 | NM_003190.5 | ENSP00000395701.2 |
Frequencies
GnomAD3 genomes AF: 0.000473 AC: 72AN: 152150Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000394 AC: 86AN: 218052Hom.: 0 AF XY: 0.000377 AC XY: 44AN XY: 116824
GnomAD4 exome AF: 0.000231 AC: 329AN: 1427174Hom.: 1 Cov.: 34 AF XY: 0.000222 AC XY: 157AN XY: 706536
GnomAD4 genome AF: 0.000473 AC: 72AN: 152268Hom.: 0 Cov.: 32 AF XY: 0.000497 AC XY: 37AN XY: 74438
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | The c.563C>T (p.T188I) alteration is located in exon 4 (coding exon 4) of the TAPBP gene. This alteration results from a C to T substitution at nucleotide position 563, causing the threonine (T) at amino acid position 188 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
MHC class I deficiency Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at